Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Loss and Comprehensive Loss

v2.4.0.8
Consolidated Statements of Loss and Comprehensive Loss (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Statement Of Income And Comprehensive Income [Abstract]        
COLLABORATION REVENUE [note 3] $ 4,929 $ 6,340 $ 16,660 $ 11,416
EXPENSES        
Research and development 9,883 13,263 26,786 24,118
General and administrative 2,676 2,473 5,433 4,973
Total operating expenses 12,559 15,736 32,219 29,091
OTHER INCOME (EXPENSE)        
Interest income 4 39 16 91
Other (4) 36 (2) 132
Gain (loss) on warrants 615 901 (106) 2,335
Total other income 615 976 (92) 2,558
Net loss (7,015) (8,420) (15,651) (15,117)
OTHER COMPREHENSIVE LOSS        
Net unrealized (loss) on securities (1) (15) (2) (21)
Total other comprehensive loss (1) (15) (2) (21)
Comprehensive loss $ (7,016) $ (8,435) $ (15,653) $ (15,138)
Basic and diluted net loss per common share [note 5] $ (0.47) $ (0.57) $ (1.05) $ (1.03)
Weighted average number of common shares [note 5] 14,987,706 14,673,771 14,855,338 14,667,244